Literature DB >> 26833738

A 19-year-old woman with sickle cell disease and pain.

Richard Ward1, Ewurabena Simpson2, Madeleine Verhovsek2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26833738      PMCID： PMC4938685          DOI： 10.1503/cmaj.150512

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Guidelines for the management of the acute painful crisis in sickle cell disease.

Authors:  David C Rees; Ade D Olujohungbe; Norman E Parker; Adrian D Stephens; Paul Telfer; Josh Wright
Journal:  Br J Haematol       Date:  2003-03       Impact factor: 6.998

2.  Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.

Authors:  Carlton D Dampier; Wally R Smith; Hae-Young Kim; Carrie Greene Wager; Margaret C Bell; Caterina P Minniti; Jeffrey Keefer; Lewis Hsu; Lakshmanan Krishnamurti; A Kyle Mack; Donna McClish; Sonja M McKinlay; Scott T Miller; Ifeyinwa Osunkwo; Phillip Seaman; Marilyn J Telen; Debra L Weiner
Journal:  Am J Hematol       Date:  2011-09-22       Impact factor: 10.047

Review 3.  Pain management for sickle cell disease.

Authors:  R J Dunlop; K C L B Bennett
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

4.  Guideline on the management of acute chest syndrome in sickle cell disease.

Authors:  Jo Howard; Nicholas Hart; Marilyn Roberts-Harewood; Michelle Cummins; Moji Awogbade; Bernard Davis
Journal:  Br J Haematol       Date:  2015-03-30       Impact factor: 6.998

Review 5.  Clinical practice. Care of the asplenic patient.

Authors:  Lorry G Rubin; William Schaffner
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

6.  Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

Authors:  Samir K Ballas; Robert L Bauserman; William F McCarthy; Oswaldo L Castro; Wally R Smith; Myron A Waclawiw
Journal:  J Pain Symptom Manage       Date:  2010-12       Impact factor: 3.612

7.  The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Authors:  Martin H Steinberg; William F McCarthy; Oswaldo Castro; Samir K Ballas; F Danny Armstrong; Wally Smith; Kenneth Ataga; Paul Swerdlow; Abdullah Kutlar; Laura DeCastro; Myron A Waclawiw
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

Review 8.  Acute pain in children and adults with sickle cell disease: management in the absence of evidence-based guidelines.

Authors:  Joshua J Field; Jessica E Knight-Perry; Michael R Debaun
Journal:  Curr Opin Hematol       Date:  2009-05       Impact factor: 3.284

9.  Improved survival in homozygous sickle cell disease: lessons from a cohort study.

Authors:  A Lee; P Thomas; L Cupidore; B Serjeant; G Serjeant
Journal:  BMJ       Date:  1995-12-16
  9 in total
  1 in total

1.  Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patients.

Authors:  Hugo Paquin; Evelyne D Trottier; Nancy Robitaille; Yves Pastore; Marie-Joelle Dore Bergeron; Benoit Bailey
Journal:  Paediatr Child Health       Date:  2018-05-31       Impact factor: 2.253
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.